1inhaler
1inhaler operates as a developer of drug delivery device.
1inhaler operates as a developer of drug delivery device.
1inhaler has raised $2.0M across 1 round. Its most recent round was a Seed of $2.0M in Nov 2025. Full funding history, investors, and team are detailed below.
Funding history
1 round on record.
Unlock the lead investor and full details for this round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.
1inhaler is featured in
Similar companies
Microplate Dx is a developer of diagnostic technology aimed at significantly reducing fatalities caused by drug-resistant infections.
Remedy Meds is a technology platform to connect with professional clinicians to provide with non-emergency care.
Uniphy is an electronic company that enables intuitive free-form Touch Interfaces that are beautiful, robust and economic.
Sentinel is a wellness firm offering trauma prevention and management through their application and scientific expertise.
AI that changes how $700B hard facilities management industry handles repairs
StirlingX is a technology company that provides AI-driven data intelligence and autonomous drone solutions.
HubBox is shaping the future of shipping with best-in-class ‘pickup at checkout’ technology
Overstone Art is a financial services company.
We help businesses innovate, from the small things that can make a big difference to more-involved 'Eureka!' projects.
Monq is an AI-powered procurement negotiation platform for enterprises.
Ponda is a material science company that makes planet-positive textiles.
Neuracore is a robot learning platform that helps to train robots and deploy intelligent behaviour.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.